Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 23, 2019 - Issue 2
Submit an article Journal homepage
326
Views
5
CrossRef citations to date
0
Altmetric
Short Report

Long-term cardiovascular safety of psychostimulants in children with attention deficit hyperactivity disorder

Annette ConzelmannDepartment of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany;
,
Stefan MüllerCentre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany;
,
Thomas JansCentre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany;
,
Götz-Erik TrottPractise for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Aschaffenburg, Germany;
,
Thomas KeilInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany; ;Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany
,
Manfred GerlachCentre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany;
&
Tobias J. RennerDepartment of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany; ;Centre of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany; Correspondence[email protected]
 show all
Pages 157-159 | Received 22 Dec 2017, Accepted 13 Aug 2018, Published online: 21 Jan 2019

Reference

  • Adler, L. A., Orman, C., Starr, H. L., Silber, S., Palumbo, J., & Cooper, K. (2011). Long-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year study. J Clin Psychopharmacol, 31, 108–114. doi:10.1097/JCP.0b013e318203ea0a
  • Awudu, G. A., & Besag, F. M. (2014). Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update. Drug Safety, 37, 661–676. doi:10.1007/s40264-014-0201-8
  • Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., … Sergeant, J. (2013). Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 54, 227–246. doi:10.1111/jcpp.12036
  • Davis, C., Fattore, L., Kaplan, A. S., Carter, J. C., Levitan, R. D., & Kennedy, J. L. (2012). The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adults. The International Journal of Neuropsychopharmacology, 15, 181–187. doi:10.1017/S1461145711001039
  • Epstein, T., Patsopoulos, N. A., & Weiser, M. (2014). Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev, 9, CD005041.
  • Gerlach, M., Banaschewski, T., Coghill, D., Rohde, L. A., & Romanos, M. (2017). What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?. ADHD Attention Deficit and Hyperactivity Disorders, 9, 1–3. doi:10.1007/s12402-017-0220-2
  • Goldfield, G. S., Lorello, C., Cameron, J., & Chaput, J. P. (2011). Gender differences in the effects of methylphenidate on energy intake in young adults: a preliminary study. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme, 36, 1009–1013. doi:10.1139/h11-098
  • Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., … Cooper, T. (2009). Sudden death and use of stimulant medications in youths. The American Journal of Psychiatry, 166, 992–1001. doi:10.1176/appi.ajp.2009.09040472
  • Kromeyer-Hauschild, K., Wabitsch, M., Kunze, D., Geller, F., Geiß, H. C., Hesse, V., … Hebebrand, J. (2001). Perzentile für den Body-Mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde, 149, 807–818. doi:10.1007/s001120170107
  • Kurth, B., & Schaffrath, RA. (2007). The prevalence of overweight and obese children and adolescents living in Germany. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS): Ergebnisse des bundesweiten Kinder und Jugendgesundheitssurveys (KiGGS) Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 50, 736–743.
  • Martinez-Raga, J., Knecht, C., Szerman, N., & Martinez, M. I. (2013). Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs, 27, 15–30. doi:10.1007/s40263-012-0019-9
  • Neuhauser, H., Thamm, M., Ellert, U., Hense, H. W., & Rosario, A. S. (2011). Blood pressure percentiles by age and height from nonoverweight children and adolescents in Germany. Pediatrics, 127, e978–e988. doi:10.1542/peds.2010-1290
  • Sagvolden, T. (2000). Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neuroscience and Biobehavioral Reviews, 24, 31–39. doi:10.1016/S0149-7634(99)00058-5
  • Sahin, S., Yuce, M., Alacam, H., Karabekiroglu, K., Say, G. N., & Salıs, O. (2014). Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder. Int J Psychiatry Clin Pract, 18, 280–287. doi:10.3109/13651501.2014.940054
  • Vitiello, B., Elliott, G. R., Swanson, J. M., Arnold, L. E., Hechtman, L., Abikoff, H., … Gibbons, R. (2012). Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. The American Journal of Psychiatry, 169, 167–177. doi:10.1176/appi.ajp.2011.10111705
  • Walitza, S., Romanos, M., Warnke, A., Greenhill, L., & Gerlach, M. 2014. Psychostimulants and Other Drugs Used in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). In: Psychiatric Drugs in Children and Adolescents, Gerlach et al. (eds), Springer, Vienna, pp 293–333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.